PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,416,410 | -28.5% | 538,559 | -4.1% | 0.17% | -24.9% |
| Q2 2023 | $1,982,201 | +14.2% | 561,530 | 0.0% | 0.22% | +4.2% |
| Q1 2023 | $1,735,128 | -27.0% | 561,530 | 0.0% | 0.21% | -29.6% |
| Q4 2022 | $2,375,272 | +75.6% | 561,530 | -1.6% | 0.30% | +29.2% |
| Q3 2022 | $1,353,000 | +13.2% | 570,840 | +36.1% | 0.23% | -20.2% |
| Q2 2022 | $1,195,000 | +18.4% | 419,322 | +19.7% | 0.29% | +42.4% |
| Q1 2022 | $1,009,000 | -59.9% | 350,224 | -57.6% | 0.20% | -20.2% |
| Q4 2021 | $2,514,000 | -13.3% | 826,762 | +99.8% | 0.26% | -59.4% |
| Q3 2021 | $2,900,000 | -29.4% | 413,692 | -7.6% | 0.63% | -14.2% |
| Q2 2021 | $4,110,000 | -1.4% | 447,701 | +4.4% | 0.74% | -2.8% |
| Q1 2021 | $4,167,000 | +637.5% | 428,680 | +679.0% | 0.76% | +527.3% |
| Q4 2020 | $565,000 | +1.8% | 55,027 | 0.0% | 0.12% | -17.7% |
| Q3 2020 | $555,000 | -15.8% | 55,027 | -13.0% | 0.15% | -12.0% |
| Q2 2020 | $659,000 | – | 63,226 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |